OR WAIT null SECS
February 08, 2022
Product variability from biopharmaceutical manufacturing to storage can significantly impact the safety and efficacy of batch-to-batch products during clinical use.
A testimonial by Hubrecht Organoid Technology in Netherlands. An organoid research facility with an ultimate goal of regenerative medicine and cell therapy.
Making an effective vaccine faces obstacles which depend on a complete line-up of pharmaceutical-grade refrigerators and freezers to maintain the necessary conditions.
Pressure for innovative products is becoming greater for pharmaceutical companies as they spend a significant amount on R&D and ways to achieve ROI in biopharma labs.
A testimonial from The National Center for Global Health and Medicine BioBank in Japan, a biobank to help develop leading next generation medicine and drugs.
A testimonial by The Inserm Unit, Institute of Regenerative Medicine Biotherapy (IRMB) in France, a facility dedicated to stem cell research and immunotherapy.